http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 09:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Press+Releases/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html <p> WOOD DALE, Ill.--(BUSINESS WIRE)-- PHC Corporation of North America (PHCNA), provider of PHCbi cell culture and sample preservation solutions across North America and Latin America, has introduced a new series of laboratory incubators featuring active hybrid humidification technology and enhanced contamination control. The new Cell-IQ® CO₂ incubator line is designed to deliver improved environmental stability for a wide range of cell culture applications. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260603887332/en/" rel="nofollow">https://www.businesswire.com/news/home/20260603887332/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260603887332/en/2834273/4/MCO-Launch-2026-PR-Banner-v3.jpg" alt="The PHCbi Cell-IQ® CO₂ Incubator Series (model numbers: MCO-233AICUVX-PA, MCO-233AICUVHX-PA, MCO-173AICUVX-PA, http://www.streetinsider.com/Business+Wire/PHC+Launches+Cell-IQ%C2%AE+CO%E2%82%82+Incubators+with+Active+Humidity+Control%2C+Creating+Critical+Stability+for+Research+Samples/26663560.html Thu, 18 Jun 2026 09:00:00 -0400 6523 A.26781740 O.13747092 O.17033881 http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Press+Releases/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html <p> BASEL, Switzerland--(BUSINESS WIRE)-- <b>Ascensia Diabetes Care</b>, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of <b>CONTOUR®COMFORT pen needles</b>, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a target="_blank" href="https://www.businesswire.com/news/home/20260601917225/en/" rel="nofollow">https://www.businesswire.com/news/home/20260601917225/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20260601917225/en/2818451/4/CONTOUR_COMFORT.jpg" alt="Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to Bring Greater Stability and Control to the Everyday Injection Experience" /><p style="font-size:85%;">Ascensia Diabetes Care Expands CONTOUR® Portfolio with CONTOUR®COMFORT Pen Needles to http://www.streetinsider.com/Business+Wire/Ascensia+Diabetes+Care+Expands+CONTOUR%C2%AE+Portfolio+with+CONTOUR%C2%AECOMFORT+Pen+Needles+to+Bring+Greater+Stability+and+Control+to+the+Everyday+Injection+Experience/26577784.html Mon, 01 Jun 2026 03:00:00 -0400 6523 A.07070846 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386 http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html <p>Ascensia Diabetes Care announced Peter Bodlund will become President and Chief Executive Officer effective April 1, 2026. Bodlund currently serves as Chief Operating Officer of the diabetes care company.</p> <p>Bodlund will succeed Koichiro Sato, who will continue as Chief Operating Officer of PHC Group and Head of PHC Group's Diabetes Management business. Bodlund will also be appointed a Corporate Officer of PHC Group.</p> <p>The leadership transition comes as Ascensia continues operations in diabetes management technology, including blood glucose monitoring systems. Ascensia is a subsidiary of PHC Holdings Corporation (TSE: 6523).</p> <p>"Peter brings proven strategic and operational leadership experience, with a clear focus on http://www.streetinsider.com/Management+Changes/Ascensia+Diabetes+Care+names+Peter+Bodlund+as+CEO/26054166.html Wed, 25 Feb 2026 02:15:11 -0400 6523 A.07070846 A.37075391 O.01196492 O.10069307 O.14891823 O.17033881 O.25443386